Somatostatin binds to the human amyloid β peptide and favors the formation of distinct oligomers

Abstract

The amyloid β peptide (Aβ) is a key player in the etiology of Alzheimer disease (AD), yet a systematic investigation of its molecular interactions has not been reported. Here we identified by quantitative mass spectrometry proteins in human brain extract that bind to oligomeric Aβ1-42 (oAβ1-42) and/or monomeric Aβ1-42 (mAβ1-42) baits. Remarkably, the cyclic neuroendocrine peptide somatostatin-14 (SST14) was observed to be the most selectively enriched oAβ1-42 binder. The binding interface comprises a central tryptophan within SST14 and the N-terminus of Aβ1-42. The presence of SST14 inhibited Aβ aggregation and masked the ability of several antibodies to detect Aβ. Notably, Aβ1-42, but not Aβ1-40, formed in the presence of SST14 oligomeric assemblies of 50 to 60 kDa that were visualized by gel electrophoresis, nanoparticle tracking analysis and electron microscopy. These findings may be relevant for Aβ-directed diagnostics and may signify a role of SST14 in the etiology of AD.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Hansen Wang

    Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada
    Competing interests
    Hansen Wang, Holds provisionary US patent on amyloid-beta binding polypeptides based on the results of this study (filing number 62/451,309)..
  2. Lisa D Muiznieks

    Molecular Medicine Program, Research Institute, The Hospital for Sick Children, Toronto, Canada
    Competing interests
    No competing interests declared.
  3. Punam Ghosh

    Department of Medical Biophysics, University of Toronto, Toronto, Canada
    Competing interests
    No competing interests declared.
  4. Declan Williams

    Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada
    Competing interests
    No competing interests declared.
  5. Michael Solarski

    Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada
    Competing interests
    No competing interests declared.
  6. Andrew Fang

    Department of Biochemistry, University of Alberta, Edmonton, Canada
    Competing interests
    No competing interests declared.
  7. Alejandro Ruiz-Riquelme

    Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6581-7132
  8. Régis Pomès

    Molecular Medicine Program, Research Institute, The Hospital for Sick Children, Toronto, Canada
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3068-9833
  9. Joel C Watts

    Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada
    Competing interests
    No competing interests declared.
  10. Avi Chakrabartty

    Department of Medical Biophysics, University of Toronto, Toronto, Canada
    Competing interests
    No competing interests declared.
  11. Holger Wille

    Department of Biochemistry, University of Alberta, Edmonton, Canada
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5102-8706
  12. Simon Sharpe

    Molecular Medicine Program, Research Institute, The Hospital for Sick Children, Toronto, Canada
    Competing interests
    No competing interests declared.
  13. Gerold Schmitt-Ulms

    Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada
    For correspondence
    g.schmittulms@utoronto.ca
    Competing interests
    Gerold Schmitt-Ulms, Holds provisionary US patent on amyloid-beta binding polypeptides based on the results of this study (filing number 62/451,309).
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6962-0919

Funding

Canadian Institutes of Health Research

  • Gerold Schmitt-Ulms

Ontario Centres for Excellence

  • Simon Sharpe
  • Gerold Schmitt-Ulms

Alberta Innovates Bio Solutions (201600028)

  • Holger Wille
  • Gerold Schmitt-Ulms

Heart and Stroke Foundation of Canada (G-15-0009148)

  • Simon Sharpe

Canada Foundation for Innovation

  • Gerold Schmitt-Ulms

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Randy Schekman, Howard Hughes Medical Institute, University of California, Berkeley, United States

Ethics

Animal experimentation: The work was performed in strict accordance with University of Toronto animal care and biosafety recommendations. All mice were handled according to procedures approved (AUP4183.3) by the animal care committee at University Health Network overseeing work at the Krembil Discovery Centre (Toronto). The handling of samples and reagents followed biosafety procedures approved (208-S06-2) by the University of Toronto Biosafety Program.

Version history

  1. Received: November 18, 2016
  2. Accepted: June 14, 2017
  3. Accepted Manuscript published: June 26, 2017 (version 1)
  4. Version of Record published: July 11, 2017 (version 2)

Copyright

© 2017, Wang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,701
    views
  • 548
    downloads
  • 34
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hansen Wang
  2. Lisa D Muiznieks
  3. Punam Ghosh
  4. Declan Williams
  5. Michael Solarski
  6. Andrew Fang
  7. Alejandro Ruiz-Riquelme
  8. Régis Pomès
  9. Joel C Watts
  10. Avi Chakrabartty
  11. Holger Wille
  12. Simon Sharpe
  13. Gerold Schmitt-Ulms
(2017)
Somatostatin binds to the human amyloid β peptide and favors the formation of distinct oligomers
eLife 6:e28401.
https://doi.org/10.7554/eLife.28401

Share this article

https://doi.org/10.7554/eLife.28401

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Ya-Juan Wang, Xiao-Jing Di ... Ting-Wei Mu
    Research Article

    Protein homeostasis (proteostasis) deficiency is an important contributing factor to neurological and metabolic diseases. However, how the proteostasis network orchestrates the folding and assembly of multi-subunit membrane proteins is poorly understood. Previous proteomics studies identified Hsp47 (Gene: SERPINH1), a heat shock protein in the endoplasmic reticulum lumen, as the most enriched interacting chaperone for gamma-aminobutyric type A (GABAA) receptors. Here, we show that Hsp47 enhances the functional surface expression of GABAA receptors in rat neurons and human HEK293T cells. Furthermore, molecular mechanism study demonstrates that Hsp47 acts after BiP (Gene: HSPA5) and preferentially binds the folded conformation of GABAA receptors without inducing the unfolded protein response in HEK293T cells. Therefore, Hsp47 promotes the subunit-subunit interaction, the receptor assembly process, and the anterograde trafficking of GABAA receptors. Overexpressing Hsp47 is sufficient to correct the surface expression and function of epilepsy-associated GABAA receptor variants in HEK293T cells. Hsp47 also promotes the surface trafficking of other Cys-loop receptors, including nicotinic acetylcholine receptors and serotonin type 3 receptors in HEK293T cells. Therefore, in addition to its known function as a collagen chaperone, this work establishes that Hsp47 plays a critical and general role in the maturation of multi-subunit Cys-loop neuroreceptors.

    1. Biochemistry and Chemical Biology
    Hao Wang, Chen Ye ... Yan Li
    Research Article

    Bacterial exonuclease III (ExoIII), widely acknowledged for specifically targeting double-stranded DNA (dsDNA), has been documented as a DNA repair-associated nuclease with apurinic/apyrimidinic (AP)-endonuclease and 3′→5′ exonuclease activities. Due to these enzymatic properties, ExoIII has been broadly applied in molecular biosensors. Here, we demonstrate that ExoIII (Escherichia coli) possesses highly active enzymatic activities on ssDNA. By using a range of ssDNA fluorescence-quenching reporters and fluorophore-labeled probes coupled with mass spectrometry analysis, we found ExoIII cleaved the ssDNA at 5′-bond of phosphodiester from 3′ to 5′ end by both exonuclease and endonuclease activities. Additional point mutation analysis identified the critical residues for the ssDNase action of ExoIII and suggested the activity shared the same active center with the dsDNA-targeted activities of ExoIII. Notably, ExoIII could also digest the dsDNA structures containing 3′-end ssDNA. Considering most ExoIII-assisted molecular biosensors require the involvement of single-stranded DNA (ssDNA) or nucleic acid aptamer containing ssDNA, the activity will lead to low efficiency or false positive outcome. Our study revealed the multi-enzymatic activity and the underlying molecular mechanism of ExoIII on ssDNA, illuminating novel insights for understanding its biological roles in DNA repair and the rational design of ExoIII-ssDNA involved diagnostics.